Previous Article | Next Article 
Journal of Virology, February 1999, p. 1492-1502, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Double-Stranded Linear Duck Hepatitis B Virus
(DHBV) Stably Integrates at a Higher Frequency than Wild-Type DHBV
in LMH Chicken Hepatoma Cells
Shih S.
Gong,1,
Anne D.
Jensen,1
C. J.
Chang,2 and
Charles E.
Rogler1,*
Marion Bessin Liver Research Center,
Department of Medicine,1 and
Department
of Epidemiology and Social Medicine,2 The
Jack and Pearl Resnick Campus of the Albert Einstein College of
Medicine, Bronx, New York 10461
Received 22 June 1998/Accepted 10 November 1998
 |
ABSTRACT |
Integration of hepadnavirus DNAs into host chromosomes can have
oncogenic consequences. Analysis of host-viral DNA junctions of DHBV
identified the terminally duplicated r region of the viral genome as a
hotspot for integration. Since the r region is present on the 5' and 3'
ends of double-stranded linear (DSL) hepadnavirus DNAs, these molecules
have been implicated as integration precursors. We have produced a LMH
chicken hepatoma cell line (LMH 66-1 DSL) which replicates exclusively
DSL duck hepatitis B virus (DHBV) DNA. To test whether linear DHBV DNAs
integrate more frequently than the wild type open circular DHBV DNAs,
we have characterized the integration frequency in LMH 66-1 DSL cells
by using a subcloning approach. This approach revealed that 83% of the
LMH 66-1 DSL subclones contained new integrations, compared to only
16% of subclones from LMH-D2 cells replicating wild-type open circular DHBV DNA. Also, a higher percentage of the LMH 66-1 DSL subclones contained two or more new integrations. Mathematical analysis suggests
that the DSL DHBV DNAs integrated stably once every three generations
during subcloning whereas wild-type DHBV integrated only once every
four to five generations. Cloning and sequencing of new integrations
confirmed the r region as a preferred integration site for linear DHBV
DNA molecules. One DHBV integrant was associated with a small deletion
of chromosomal DNA, and another DHBV integrant occurred in a telomeric
repeat sequence.
 |
INTRODUCTION |
Hepadnaviruses infect the liver
where they cause acute or persistent infection of hepatocytes,
depending on the nature of the immune response mounted by the host
(7). Infectious hepadnavirus virion particles contain
open circular (OC) DNA formed in the cytoplasm (30). These
nucleocapsids contain pregenomic RNA and the viral reverse
transcriptase (P protein) plus additional chaperone molecules
(14). The normal replication mechanism involves reverse transcription of the pregenomic RNA in nucleocapsids to form a full-length minus-strand DNA which contains a direct duplication of a
nine-base sequence on its 5' and 3' ends. This sequence is called the
terminally redundant r sequence (24). In the majority of
cases, the viral DNA plus strand is initiated and synthesized from a
specific position at the 5' end of the minus strand (the DR2 site).
This mechanism leads to the formation of OC viral DNA molecules in
infectious virions (7, 16, 32, 33).
However, in approximately 5% of nucleocapsids, plus-strand synthesis
is initiated from the 3' end of the minus strand and this leads to the
formation of a double-stranded linear (DSL) viral DNA molecule
(29). DSL DHBV DNA can be circularized in hepatocytes which
they infect and they replicate by a mechanism called illegitimate
replication (38). This term was used for this type of
replication because it leads to a very high frequency of mutant virus
production, which amplifies itself through successive rounds of viral
DNA replication (38).
The hepadnavirus replication mechanisms are unique for a virus
replicating via reverse transcription because DHBV pregenomic RNAs are
formed from a nuclear CCC DHBV DNA molecule and not an integrated
provirus. Interestingly, one of the most striking sequelae of
persistent infection with the mammalian hepadnaviruses is the occurrence of hepatocellular carcinoma (HCC) in the host liver (1,
22, 31). Molecular analysis of genomic DNA from such HCCs
generally reveals the presence of clonally propagated viral DNA
integrations (20, 22, 37). Therefore, while integration and
provirus formation are not required for replication, integration does
occur in host chromosomes during persistent infection (22, 37). Interestingly, molecular analysis of the integrations has shown that virtually all of them contain viral genomes with deletions and rearrangements. Thus, the integration process has been viewed as a
pathway in which viral DNA normally destined for CCC DNA formation is
diverted into nonfunctional integrations (8, 9, 20, 23). The
presence of these integrations can have oncogenic consequences for the
host since the integrations contain enhancers which can activate
cellular promoter which are normally silent (5-7).
In the case of HCCs arising in woodchucks with persistent woodchuck
hepatitis virus (WHV) infection, molecular analysis of cloned WHV DNA
integrations has revealed a dramatic example of common activation of
myc family proto-oncogenes (5-7, 11, 19). Specifically, when WHV DNA integrates near N-myc2, it
generally activates the expression of a normally silent
N-myc2 retroposon via an enhancer insertion mechanism
(36). A second common integration site (the WIN locus) is
located approximately 250 kb upstream from the N-myc2 gene
(6). The mechanism by which integration at this site leads
to activation of the N-myc proto-oncogene has yet to be
described. In many other cases, integrations of hepatitis B virus (HBV)
are implicated in cancer by their presence in or near growth regulatory
genes. Altered expression of a number of genes by HBV DNA integrations
have been reported, such as cyclin A (35), retinoic acid
receptor (4), hst-1 oncogene (12), and
mevalonate kinase (10). In the case of HBV, a commonly
activated protooncogene has not yet been identified in human HCCs.
However, the presence of many HBV DNA integrations at sites of
chromosomal DNA deletions (23) and translocations
(13) have implicated them as general mutagenic agents
(8, 22).
Since molecular evidence clearly implicates hepadnavirus DNA
integrations as potent carcinogenic agents, our aim has been to
understand the natural history of integrations and the factors which
either increase or decrease their frequency during persistent infections (21). Such an understanding may allow us to
devise strategies to block or reduce their occurrence and reduce the risk of hepatocarcinogenesis in individuals with persistent infection. With this goal in mind, our laboratory has developed a single-cell cloning approach to study the natural history of integrations in
growing cells. This approach detects new hepadnavirus integrations which are stable during the clonal growth of infected hepatoma cells
(9).
Initially, we utilized the LMH-D2 cell line, which replicates circular
(wild-type [WT]) duck hepatitis B virus (DHBV) (2, 15).
These studies demonstrated that new DHBV DNA integrations could be
detected in approximately 10 to 20% of the DNAs from LMH-D2 subclones
(8). Cloning and sequencing of one of the DHBV DNA
integrations (intb) revealed a structure strikingly similar to that of episomal DSL DHBV virion DNAs (9). To investigate whether linear episomal DHBV molecules might be more efficient integration substrates than circular DHBV DNAs, we produced a cell line
(LMH 66-1 DSL) which produces only linear DHBV (17). We have
investigated the frequency and natural history of DHBV DNA integrations
in subclones of the above cell line and compared our data with
previously reported data for integration of WT circular DHBV DNAs
(8). Our calculations predict a frequency of one integration
per three cell generations for linear DHBV versus one integration per
four to five generations for the circular DHBV. Finally, cloning and
sequencing of several new DHBV integrations has revealed some common
features among the integrations and suggests mechanisms for DHBV DNA integration.
 |
MATERIALS AND METHODS |
Cell culture.
The LMH chicken hepatoma cell line (2,
15) was a generous gift from William Mason (Institute for Cancer
Research, Philadelphia, Pa.). The plasmid 66-1 (17), which
contains a 1.5× DHBV genome with five nucleotide mutations
(29) in the 5' DR1, was obtained from Dan Loeb (Madison,
Wis.). The LMH cells were transfected with the plasmid 66-1 along with
a selectable marker, pSV2Neo. G418-resistant cell clones were expanded
and maintained in Dulbecco's minimal essential medium-F12 with 10%
fetal bovine serum and 200 µg of G418/ml. Single-cell subcloning of
the LMH-DSL cell line was performed as previously described
(8). Briefly, dilutions containing 100 to 200 single cells
of the LMH-DSL cell line generated from the plasmid 66-1 were mixed
with 1 × 105 G418-sensitive helper LMH cells and
plated onto 100-mm dishes. The mixed culture was grown in medium
without G418 for 2 days, and G418 (200 µg/ml) was then added to
remove the helper cells. G418-resistant subclones were picked and
transferred to 12-well culture plates and then to 100-mm dishes where
they grew to 5 × 106 to 10 × 106
cells before being harvested for analysis. This represents
approximately 23 generations of cell growth.
Analysis of subclone DNA.
Total nuclear DNA of the LMH 66-1 cell line and its subclones was isolated as previously described
(8). Briefly, the cells in culture dishes were trypsinized
and lysed in the buffer containing 50 mM Tris HCl (pH 7.5), 1 mM EDTA,
5 mM MgCl2, and 0.5% Nonidet P-40. The pelleted nuclei
were then lysed with 0.2% sodium dodecyl sulfate and treated with
proteinase K (200 µg/ml) overnight, and the nucleic acids were
extracted once with phenol and once with chloroform and were
precipitated with enthanol. The cytoplasmic fraction was processed to
isolate viral core particle DNA. It was treated with DNase I (100 µg/ml) for 1 h at 37°C. The reaction mixture was adjusted to
contain 100 mM NaCl, 10 mM EDTA, 0.2% sodium dodecyl sulfate and
proteinase K (200 µg/ml) and incubated overnight. The viral DNA was
extracted as described above with phenol-chloroform. To isolate DHBV
DNAs from the culture medium, DHBV virions secreted into the culture
medium were concentrated with 15% polyethylene glycol and 1 M NaCl at
4°C. Virion DNA was isolated as described above for the cytoplasmic
core particle DNA. For Southern blot analysis (27), nuclear
or cytoplasmic DNA was digested with restriction enzymes overnight,
electrophoresed through a 1% agarose gel, transferred to a Zetabind
membrane, and hybridized with radiolabeled probes made by random
priming (9).
Cloning and analysis of DHBV integrations.
To clone the DHBV
integrations, total nuclear DNA isolated from LMH-DSL P1(5)-4 subclone
was digested with SacI, ligated with lambda DASH II vector,
and packaged with Gigapack extracts (Stratagene, La Jolla, Calif.). The
genomic library was then screened with radiolabeled total DHBV DNA. The
DHBV-positive phage clones were purified by two more cycles of plating
and screening. Purified phage clones DNAs were digested with
SacI to release the insert, and the DHBV DNA containing
fragments were subcloned in the pBluescript II plasmid.
 |
RESULTS |
Establishment of a cell line that produces DSL DHBV DNA.
To
investigate the frequency of integration of DSL DHBV molecules, we
constructed a LMH cell line by using a previously characterized mutant
DHBV, designated 5/12 (29), which was expected to produce DSL DHBV due to mutations in one copy of the DR1 sequence (five base
substitutions in the 12-bp DR1). These mutations only allow virus DNA
to be synthesized by the in situ priming mechanism (Fig. 1). The plasmid 66-1, which contained a
1.5× genome construct of the mutant 5/12 DHBV DNA was a gift from Dan
Loeb. This plasmid was transfected into the LMH cells along with a
selectable marker, PSV2neo (Fig. 1). A G418-resistant clone which
secreted DHBV into the culture medium was expanded and was designated
LMH 66-1 DSL.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic diagram of the 66-1 plasmid. Plasmid 66-1 (17) was used for stable transfection of the LMH chicken
hepatoma cells. It contains larger than genome size (3-kbp
EcoRI fragment) DHBV3 (28) DNA for supporting
viral replication. The BamHI-EcoRI (nucleotides
1658 to 3021) fragment was joined to the EcoRI monomer to
create a "1 1/2mer" of DHBV DNA expression vector. The 5' (left)
DR1 (boxed) sequence contains 5-nucleotide substitutions from the WT
DR1 located in the 3' end (right). The pregenome RNA transcribed
(arrow) from the vector will contain mutations in only the 5'
redundancy.
|
|
DHBV DNAs in LMH 66-1 DSL cells and secreted virions.
Southern
blot analysis of DHBV virion DNAs secreted from LMH 66-1 DSL cells
revealed two species of molecules. The major species was DSL DHBV DNA,
and a very minor species migrated at the position of single-stranded
(SS) DHBV DNA. No OC DHBV DNA molecules were detectable in the secreted
virus preparations. In contrast, wild-type DHBV virions produced by
LMH-D2 cells contained OC DHBV DNA molecules with a minor fraction of
DSL molecules and little detectable SS DHBV DNA (Fig.
2).

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 2.
Analysis of DHBV DNAs expressed from the LMH 66-1 DSL
cell line. wt, WT DHBV produced by LMH-D2 cells; 66-1, virus present in
LMH 66-1 DSL cells. Lanes: virion, viral DNA isolated from secreted
virons; cyto, cytoplasmic DHBV DNAs; nul, nuclear DHBV DNAs; M,
HindIII lambda phage marker fragments. The positions for
open circular (OC), double-stranded linear (DSL), and single-stranded
(SS) DHBV DNAs are indicated. Viral DNAs produced from the LMH 66-1 DSL
and LMH-D2 (WT DHBV) cell lines were isolated and analyzed by Southern
blotting as described in Materials and Methods. The cells were
fractionated into nucleus (nul) and cytoplasm (cyto) fractions from
which DHBV DNAs were extracted. The probe used was a random primed
total DHBV DNA. Molecular weight standard (lane M) is a radiolabeled
HindIII digest of lambda phage DNA.
|
|
In concordance with this picture, the cytoplasm of LMH 66-1 DSL cells
contained an overwhelming majority of DSL and SS DHBV
DNAs and
replication intermediates (Fig.
2). Only a very small
component of DHBV
molecules migrating in the position of open
circles was observed and
these were observed only when the blot
was highly overexposed for the
cytoplasmic fraction, as shown
in Fig.
2. Thus, the OC molecules are an
extremely small fraction
of the DHBV DNA molecules in the cytoplasm.
This very small minority
of OC DNAs could be synthesized by
translocation or mismatch priming
of the mutated plus-strand primer.
Alternatively, these molecules
could have arisen by circularization of
DSL DHBV DNA molecules
after their extraction. This could occur by end
melting and hybridization
of homologous r sequences at their ends. The
specific structures
of the very minor component of OC molecules was not
determined.
DNA extracted from the nuclei of LMH 66-1 DSL cells contained DSL and
SS DHBV DNAs. Interestingly, there was no detectable
CCC DHBV DNA in
the nuclei of LMH 66-1 DSL cells. CCC DHBV DNAs
are protein free and
would migrate just ahead of the 2.0-kb DNA
marker (Fig.
2), and we
should have been able to detect as little
as one CCC DHBV DNA molecule
per nucleus. It is not known whether
the DSL or SS DHBV DNAs in the
nuclei of LMH 66-1 DSL cells are
protein free as are the CCC DNAs in
the LMH-D2 cells. These data
demonstrate that DSL DHBV DNA molecules
are not circularized in
the nucleus of LMH hepatoma cells. This is in
contrast to the
circularization of DSL DHBV DNA, which occurs in
primary duck
hepatocytes (
38). This property of LMH cells
allowed us to carry
out experiments without the complication of OC DHBV
molecules
being present in the nuclei of LMH 66-1 DSL cells. The
pregenomic
DHBV RNAs in these cells were produced from the transfected
transgene
DNA which was present in the cells. The transgene DNAs which
had
integrated into the chromosome are designated Tr and were
detectable
when the genomic DNA was digested with
PstI, (see
Fig.
4).
Single-cell subcloning of the LMH 66-1 DSL cell line revealed a
high frequency of new DHBV integrations.
In order to estimate the
frequency of stable DHBV integrations in the LMH 66-1 DSL cell line, we
produced single cell subclones from the parental cells. A schematic of
three cycles of subcloning protocol, illustrating the number of
subclones in each cycle and the subclone numbers of lineages which were
carried through sequential subcloning protocols, is illustrated in Fig.
3. All the nuclear DNAs were harvested
from colonies which were allowed to grow through 23 to 24 cell
divisions to reach approximately 4 × 106 to 8 × 106 cells. The genomic DNAs were digested with restriction
enzyme PstI, whose recognition sequence is not present in
the DHBV DNA of the mutant DHBV used in our experiments (28,
29). Therefore, each new band on a Southern blot, which was
larger than DSL DHBV DNA, should represent a DHBV DNA integration.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 3.
Flow diagram of three cycles of single-cell subcloning
of the LMH 66-1 DSL cell line. P, parental cell line used for initial
subcloning. 1st, The first cycle of subcloning included 13 subclones,
and subclones 5 and 8 were selected for a second round of subcloning;
2nd, six second-cycle subclones were derived from colony 5, and 12 second-cycle subclones were derived from colony 8; 3rd, third-cycle
subclones were derived from second-cycle subclones P1(5)-5 and P1(5)-6,
for a total of six third-cycle subclones. Open circles indicate
subclones which were further subcloned, and solid circles denote
subclones which were not further subcloned.
|
|
Southern blot analysis of genomic DNAs from the parental clone and all
13 first-generation subclones are shown in Fig.
4.
The two bands in the Southern blot
marked Tr were from the transfected
DNA used to generate the cell line,
and these were present in
all the subclones. Another DHBV DNA band of
approximately 7 kb
was present in the parental DNA and also in 9 of 13 of the first-cycle
subclones. Therefore, this integration occurred
early in the selection
of the LMH 66-1 DSL cell line and is present in
most but not all
of the cells. Alternatively, it could have been
present in the
initial cell used to generate the cell line and was
subsequently
lost from some cells. In either case, since it was present
in
the original parental DNA preparation and was common in the first
cycle subclones, it was not counted as a new integration in our
experiments.

View larger version (124K):
[in this window]
[in a new window]
|
FIG. 4.
Southern blot analysis of DHBV DNA integrations in the
first-generation subclones of the LMH 66-1 DSL cell line. Lanes: P,
parental DNA; 1 to 13, DNAs from 13 first-cycle subclones. Tr,
transgene bands. OC, DSL, and M are as defined in the legend for Fig.
2. Arrowheads indicate new DHBV DNA integrations in the subclones. The
genomic DNAs were digested with PstI, a DHBV3 noncutter, and
analyzed by Southern blotting with a total DHBV DNA probe. The LMH 66-1 DSL cell line contained two high-molecular-weight DNA bands (Tr)
derived from integration of the plasmid 66-1 during stable transfection
that are retained in all the subclones.
|
|
Careful analysis of the new integration bands (above the DSL DHBV DNA
band), revealed many bands with varied intensities.
Previous subcloning
data has shown that the variation in intensity
is most often caused by
integrations not present in all the cells
in the colony (
8,
9,
21). This means that the integration
occurred after the first
cell division initiating the colony.
The total number of new
integrations was 20, and at least one
new integration was present in
all of the subclones (Fig.
4).
Eight subclones contained a single
candidate new integration while
four subclones contained two, and one
subclone (no. 2) contained
four candidate new integrations. The
integrated transgene bands
were present in the parental line and were
stable throughout our
experiments.
The LMH 66-1 DSL subcloning data were in sharp contrast to the data we
had previously obtained for LMH-D2 cells which replicate
WT DHBV.
First-generation subcloning of that cell line revealed
only two
candidate new integrations in 12 subclones (
8). Therefore,
the new data strongly suggested that the integration frequency
in our
new LMH 66-1 DSL cell line was much higher than that of
LMH-D2
cells.
To obtain a more accurate estimate of the integration frequency in LMH
66-1 DSL cells, it was necessary to carry out subsequent
generations of
subcloning, in which we grew the cells at the same
rate for a known
number of cell generations. We chose first-generation
subclones 8, which contained one new integration band at approximately
23 kb (Fig.
3, and Fig.
4, lane 8), and subclone 5, which contained
two new
integrations at approximately 5 and 7 kb (Fig.
3, and
Fig.
4, lane 5)
for further lineage
analysis.
Second-generation subcloning of LMH 66-1 DSL cells.
The
second-generation subclones were grown for 23 to 24 cell divisions
(4 × 106 to 8 × 106 cells) before
DNA was prepared from each subcloned cell population for Southern blot
analysis. New integrations which would be detected by this analysis
would have occurred during the growth of the first-cycle subclone or
during the first few cell divisions of the second-cycle subclone (as
illustrated in Fig. 3). The results of the Southern blot analysis of
second-cycle single-cell subclones are shown in Fig.
5 and 6.

View larger version (125K):
[in this window]
[in a new window]
|
FIG. 5.
Southern blot analysis of the DHBV DNA integrations in
the P1(8) lineage second-cycle subclones. Lanes: P, parental DNA;
P1(8), nuclear DNA from first-cycle subclone P1(8); 1 to 12, nuclear
DNAs from 12 second-cycle subclones derived from P1(8), digested with
PstI, and analyzed by Southern blotting. Arrowheads indicate
new DHBV DNA integrations detected in the second-cycle subclones. P1(8)
had contained one new DHBV DNA integration at about 23 kb which was
present in all the second-cycle subclones.
|
|

View larger version (79K):
[in this window]
[in a new window]
|
FIG. 6.
Southern blot analysis of the DHBV DNA integrations in
the P1(5) lineage second-cycle subclones. Lanes: P1(5), nuclear DNA
from first-cycle subclone P1(5); 1 to 6, nuclear DNAs from six
second-cycle subclones derived from P1(5). Long arrows at left point to
new integrations in first-cycle subclone P1(5) which segregate among
second-cycle subclones. Smaller arrows within the blot point to new
integrations in the second-cycle subclones. Abbreviations are as
defined in the legend for Fig. 2.
|
|
First-generation subclone P1(8) had contained one new integration
identified as a
PstI fragment of about 23 kb. This
integration
was present in 100% of the second-generation subclones,
which
showed that it was present in the initial cell that produced the
first-generation clone 8 (Fig.
5). Therefore, the 23-kb band was
not
included in the calculations which determined the number of
integrations for this second-generation lineage. Southern blot
analysis
of the lineage 8 subclones revealed new integrations
in 8 of 12 subclones (Fig.
5). Of the subclones with new integrations,
one had two
new integrations and remarkably, three had three new
integrations. The
total number of new integrations was 15 for
12 subclones (Table
1).
The first-generation P1(5) subclone contained two new DHBV integrations
(Fig.
4, lane 5; Fig.
6). One of the second-generation
subclones
[P1(5)-3 (Fig.
6, lane 3)] contained the larger integration.
This
integration had been a "weak" integration in the first cycle
and
accordingly, the second-cycle subcloning revealed it was present
in
only one of six of the subclones. The other integration was
present in
the other five second-cycle subclones. This segregation
illustrated
that those integrations occurred in different progeny
cells during the
early clonal growth of the first-generation P1(5)
population.
Three of the six P1(5) second-cycle subclones contained new DHBV
integrations (Fig.
6). One subclone [P1(5)-5 (Fig.
6, lane
5)]
contained one new integration and two subclones contained
three
[P1(5)-2 and -4 (Fig.
6, lanes 2 and 4)]. Thus, 50% of the
second-generation subclones contained a new integration, yet the
total
number of new integrations was greater than the number of
subclones (7 per 6 subclones) (Table
1). Summarizing the data
for the clone 8 and 5 second-cycle lineages, 39% of the subclones
did not contain a new
integration. However, 21 new integrations
were detected among the 18 second-generation subclones for an
average of 1.2 new integrations per
subclone (Table
1).
Third-generation subcloning of LMH 66-1 DSL cells.
To test
whether our second-cycle integration data represented a true
steady-state picture of the stable integration frequency in LMH 66-1 DSL cells, we conducted a third-cycle subcloning experiment. To do
this, we used single cell subcloning of the second-cycle clone
populations P1(5)-5 and P1(5)-6 (Fig. 6, lanes 5 and 6, respectively).
As shown in Fig. 7, five of six
third-cycle subclones contained new DHBV integrations that were not
detected in the parental populations (Fig. 7). Three subclones
contained one new integration, one subclone contained two new
integrations, and one subclone contained three new integrations. A
total of eight new integrations were detected in six subclones for an
average of 1.3 integrations per subclone (Table 1).

View larger version (76K):
[in this window]
[in a new window]
|
FIG. 7.
Southern blot analysis of DHBV DNA integrations in the
third-cycle subclones of the P1(5) lineage. Lanes: P1(5)-5 and P1(5)-6,
DNAs from second-cycle subclones used to derive third-cycle subclones;
1 to 3, three third-cycle subclones each derived from the respective
second-cycles subclones. Abbreviations are as defined in the legend for
Fig. 2.
|
|
Combining the integration frequencies for the second- and
third-generation subclones, we observed that 33% (8/24) of the
subclones
did not contain a new integration. However, the total number
of
new integrations, (30 per 24 subclones) averaged 1.25 integrations
per subclone (Table
1). This was due to the presence of greater
than
one new integration in 33% (8/24) of the subclones. This
was a
dramatic increase over the previously observed integration
of LMH-D2
subclones, in which an average of 84% (49/59) of the
second- and
third-generation subclones did not contain a new integration,
and in
which there were only 0.18 new integrations observed per
subclone
(Table
1).
The structures of the DHBV DNA integrations in LMH 66-1 cells
resemble linear DHBV DNA molecules but often with a few nucleotides
deleted from either terminus.
Having established a cell line that
integrated DHBV DNA at a high frequency, we wanted to study the
integration mechanism by comparing the structure of the newly
integrated DHBV DNA with that of episomal DSL DHBV molecules. To do
this, we cloned three new integrations from subclone P1(5)-4 (Fig. 6,
lane 4). We generated a SacI genomic library in Lambda phage
DASH II vector from genomic DNA of subclone P1(5)-4. Once the clones
were plaque purified, DNA was prepared, and the complete integrated
DHBV DNA molecule in each integration was sequenced along with
immediate flanking cellular DNA. Analyses of the three viral DNA
integrations in the LMH P1(5)-4 clone are shown in Fig. 8 in comparison
to the structure of DSL DHBV produced by LMH 66-1 cells.
Each of the DHBV DNA integrations contained one copy of the DHBV genome
that was generally colinear with a DSL DHBV DNA. However,
the viral DNA
sequences at the junctions with cellular DNA differed
in each clone,
yet at the same time, they were all closely clustered
within 30 nucleotides of either terminus of the minus strand.
The viral junctions
at the 3' terminus were all localized in the
end 18-nucleotide region
that would contain an RNA primer following
synthesis of the DSL DNA by
the so-called in situ priming mechanism
(Fig.
8A). The three DHBV DNA integrations
isolated from the LMH
66-1 subclones contained all or part of the DR1
sequence and each
had retained the mutations constructed in the DHBV
expression
plasmid.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 8.
Structure of three DHBV DNA integrations from the LMH
66-1 DSL cell line. (A) Top section labeled DSL is a schematic map of a
DSL DHBV virion DNA produced from LMH 66-1 DSL cell line and the
specific minus-strand DNA sequences present at each end of the DSL
molecule. Curvy line shows the 5' end of the plus strand (+) of DSL
DHBV DNA, which contains an 18-nucleotide RNA primer including the
r-terminal redundancy region. Nucleotides in bold in DR1 indicate the
mutated nucleotide changes to produce DSL DNAs. Section labeled LMH-DSL
(int1, int2, and int3) is a map of three new
integrations cloned from LMH-DSL subclone P1(5)-4 (integration bands
seen in Fig. 6, lane 4). Vertical dashed lines denote left and right
viral junctions with cellular DNA. LMH-D2 intb is a
previously reported WT DHBV integration (9) with a structure
similar to that of DSL DNA. Complete DHBV integrations and their
immediate cellular flanking DNA were sequenced manually or by an
automatic sequencer using oligonucleotides derived from the DHBV genome
and cellular DNA. Slashes (//) in the diagram represent the
uninterrupted DHBV genome. (B) The unintegrated cellular locus for LMH
66-1 DSL int3 was isolated by PCR from the untransfected LMH
cell line using oligonucleotides derived each from the left and right
flanking cellular DNA of int3. One specific fragment was
amplified by PCR from the LMH cell line from the oligonucleotide
primers (underlined) and was sequenced. The shaded sequence represents
region of the unintegrated locus DNA that was not present in the
int3 flanking cellular DNA. The two arrows indicate possible
sites of deletion of cellular DNA during int3 integration.
(C) DHBV DNA at the junction site of int3 (upper-case
letters) and cellular genomic DNA sequences across the left and right
junctions of int3 (lower-case letters) were aligned for
comparison. Vertical lines denote the homology between the viral and
cellular DNA sequences at the junctions. The shaded sequences are
int3 junctional sequences.
|
|
Integration at DHBV int3 resulted in a small deletion
of chromosomal DNA.
We next isolated the unintegrated locus of
chromosomal DNA corresponding to the chromosomal integration site for
int3 (Fig. 8A). This was done by PCR using oligonucleotide
primers derived from the left and right flanking cellular DNA. The
complete sequence of the normal cellular integration site is shown in
Fig. 8B. Sequence analysis of the intact site versus the left and right
junction sequences of int3 revealed that a deletion of 22 bp
of the chromosomal DNA occurred at the DHBV integration locus (Fig.
8B). Alignment of the unintegrated locus and DHBV sequences across the
junctions of int3 further revealed a 2- to 4-bp homology at
each of the viral-cellular DNA junctions (Fig. 8C). This short
junctional homology between the hepadnaviral and cellular DNAs has
previously been observed and most likely has a role in the integration mechanism.
DHBV integration int1 is associated with telomere
repeat sequences.
Sequence analysis of the right-hand flanking
cellular DNA for the DHBV int1 revealed 17 copies of the
sequence aaccct, which is a telomere-associated repeat sequence
conserved in vertebrates (Fig. 9A)
(18). While hepadnaviral DNA integrations have previously been found to be associated with the cellular repetitive DNA
(25), no report has shown them to be directly linked to
telomere repeat sequences.

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 9.
Integration of int1 in the telomere repeat
sequence and repetitive DNA. (A) Schematic diagram of the genomic
SacI fragment containing DHBV DNA integration
int1 isolated from subclone P1(5)-4. Filled rectangle
indicates the DHBV DNA in the integration (junctions shown in Fig. 8).
aaccct indicates the 17 copies of the telomere repeat sequence located
at the right junction of the integration. Open rectangle represents
flanking cellular DNA. Left and right denote the size and location of
the flanking probes used in the Southern blot in panel B. (B) Analysis
of the integration site of int1. Left and right junction
probes: Southern blots of subclone DNAs digested with either
SacI or PstI and hybridized with either the left
or right junction probes as denoted. Lanes: 1, untransfected LMH cells;
2, Parental LMH 66-1 DSL DNA; 3, P1(5)-4 subclone DNA. The probes were
made from left or right flanking cellular DNA of int3
regions indicated in panel A. The probe regions were amplified by PCR
from the cloned genomic SacI fragment, subcloned into
plasmid vectors, and isolated for use. For appropriate analysis of the
banding patterns, refer to the text. M, marker DNA.
|
|
Since telomeres are often at the end of chromosomes, this raised the
possibility that the integration had linked the end of
one chromosome
with another chromosome fragment in a translocation
mechanism. To
investigate this, we mapped the DHBV integration
site using flanking
sequence probes from each side of DHBV
int1.
One problem we
had was that both probes hybridized to repetitive
DNA elements in the
chicken genome (LMH cells are chicken hepatoma
cells). As shown in Fig.
9B, we detected numerous distinct bands
with both probes in the
untransfected LMH cell line (Fig.
9B,
lane 1) and also in the LMH 66-1 parental populations (Fig.
9B,
lane 2), and the subclone P1(5)-4 that
contained
int1 (Fig.
9B,
lane 3). The results indicated that
both sides of the flanking
cellular DNA of the integration
int1 contained moderately repetitive
sequences. Due to the
presence of the repeated sequences in each
flanking probe, we could not
determine conclusively whether a
chromosome rearrangement had occurred
at the integration site.
However, the right cellular flanking DNA
detected stronger hybridizing
bands than the left flanking
DNA.
 |
DISCUSSION |
Previous work had suggested that DSL molecules of DHBV might serve
as precursors of new DHBV integrations which occur in LMH cells
(9, 29). We reasoned that a cell line which produced DSL
molecules might exhibit a higher frequency of DHBV DNA integration than
a cell line which produced WT OC DHBV DNA. To test this hypothesis, we
generated an LMH cell line which produced exclusively DHBV virions
containing DSL DHBV DNA molecules (17). Interestingly, the
successful establishment of the LMH 66-1 DSL cell line demonstrated that LMH chicken hepatoma cells lack a mechanism for efficient circularization of DSL molecules. In contrast, primary duck hepatocytes circularize DSL DHBV DNAs very efficiently (38). Such
circularization would be expected to reduce the pool of linear DHBV DNA
integration precursors. This in turn could explain why integration is a
rare event in duck liver and why congenitally infected ducks generally do not develop liver cancer.
We used a previously established single-cell subcloning approach to
measure the frequency of stable new DHBV DNA integrations which
occurred in the cells. In our Southern blot assay, integrations which
occurred after the third cell division of colony growth would be
undetectable since they would be present in the subclone in less than
one of eight of the cells in the final colony. In order to be able to
normalize our data between subclones, we grew each subclone to
approximately 8 × 106 cells or 24 cell generations.
Subcloning of the parental cell population revealed a 100% frequency
of new integrations in the first-cycle subclones. To normalize our data
to a defined number of cell generations (8, 9), second- and
third-cycle subclones were grown for approximately 24 cell divisions
(8 × 106 cells) before harvesting and preparation of
genomic DNAs for Southern blot analysis. These procedures matched those
carried out earlier for WT DHBV subcloning and allowed direct
comparison with our previously published data.
The combined second- and third-generation integration data revealed
that 66% of the LMH 66-1 DSL subclones contained new integrations compared to only 16% of comparable LMH-D2 (WT) subclones. This difference was significant at the P = 0.0001 level
using a chi-square test. In addition, 33% of the LMH 66-1 DSL
subclones contained more than one new integration compared to only 1 to
2% of the LMH-D2 (WT) subclones. As a consequence, the ratio of new
integrations per subclone for the LMH 66-1 DSL cell line was 1.25 and
for LMH-D2 cells it was only 0.18.
The Southern blot approach we used can detect only the subset of DHBV
integrations which are stable in host chromosomes. Although we have
observed the loss of specific integrations in LMH lineages, such losses
(of previously stable integrations) are rare. Therefore, in our
experiments, when we followed cell lineages through three subcloning
cycles, we observed a continuous accumulation of stable new
integrations. These data suggest that the presence of one integration
does not block the acquisition of additional new integrations in the
same cell. Furthermore, the percentage of cells which do not contain an
integration should decrease with every integration cycle.
Therefore, the percentage of subclones which do not contain a new
integration should steadily decrease as a colony goes through successive cell generations. For example, if after three generations (23 cells) one of eight cells in the colony would acquire
an integration, that would leave seven-eighths of the cells without a
new integration. After three more generations, seven-eighths × seven-eighths (or 7/82), would not have an integration. A
mathematical formula to describe the steady decrease in the percentage
of cells without an integration is X = (1
1/2k)t where X = the
percentage of subclones which do not contain a new integration (from
Table 1), t = the number of integration cycles needed
to arrive at the percentage of clones which do not contain an
integration, and k = the number of generations per integration cycle.
We measured X = 33% of the DSL subclones without a new
integration. If we hypothesize that k = 3, solving for
t we get t = 8.3. Therefore, our
calculations predict that it should take tk or 24.9 generations of cell growth to yield a population in which 33% of the
cells do not contain an integration. This prediction fits closely with
our data, since we grew our subclones approximately 24 generations
before harvest. Thus, the data and mathematical model fit a frequency
of one stable integration per three generations for DSL DHBV DNAs in
LMH 66-1 DSL cells.
In contrast, for WT DHBV, we measured X = 84% of the
subclones without a stable new integration. If we hypothesize that
k = 5, solving for t we get t = 5.5. Therefore, it should take 5.5 × 5, or 27.5 generations
to reach the integration frequency we observed in the LMH-D2 subclones.
This is slightly greater than the 24 generations we grew the LMH-D2
subclones. Therefore, we estimate that the integration frequency for WT
DHBV in LMH-D2 cells is approximately one integration per four to five generations.
Once we estimated the integration frequency (k = 3 for
DSL and approximately 5 for WT), we wanted to predict the total number of integrations which would occur in a colony after t cycles
of integration where one integration occurs every k
generations. We let St equal the total number of
integrations at the tth cycle, where one cycle is equivalent
to k generations. Also, we let Nt be
the total number of cells at the tth cycle, (i.e.,
kt generations). Thus, St = t(2k)t
1; t = 1,2, ... ; and
Nt = 2kt. Thus, the ratio of number
of integrations per cell at the tth cycle can be derived as
follows: St/Nt = t(2k)t
1/2kt = t2kt
k/2kt = t/2k where
k = 1, 2, 3 and t = 1, 2, 3.
According to the formula, for colonies grown 24 generations, the
following ratios are predicted. When k = 2, 3, 4, or 5, then St/Nt = 3.0, 1.0, 0.375, or
0.15, respectively. The experimentally determined ratio of new
integrations per clone was 1.25 for LMH 66-1 DSL clones, fitting a
k = 3 frequency, and the ratio for LMH D2 clones was
0.18, fitting a k = 5 frequency. Therefore, using two
different mathematical approaches, i.e., the calculation of the
percentage of subclones without an integration and the calculation of
the total number of integrations per subclone, the data analysis
suggest a frequency of one integration per three generation for DSL
DHBV DNAs versus one integration per four to five generation frequency
for WT DHBV DNAs.
DHBV integration mechanisms.
The structures of the three DHBV
integrations isolated from the LMH 66-1 subclones bear a striking
resemblance to a complete DSL DHBV DNA molecule and may be derived
directly from the virion DSL DNA. The structures of LMH 66-1 DSL cell
line integrations were also comparable to intb, that we
previously cloned from LMH-D2 cells (Fig. 8A). intb contains
a complete DHBV genome with only three nucleotides deleted from the 3'
terminus of the minus strand. The heterogeneity of the viral junctions
of DHBV integrations in LMH 66-1 DSL cells is very similar to
integrations in LMH-D2 cells (9a). An overwhelming majority
of the viral junctions are localized in the 70-bp region bracketed by
the DR sequences. Similar preference of the viral junction sites has
been observed for hepadnaviral DNA integrations isolated from tumors
(3, 26, 34). One explanation for the highly preferred DHBV
DNA junctions in LMH cells is that the majority of the DNA integrations are derived from linearized DHBV DNAs or from the minority linear forms
present in the WT DHBV population.
The most frequent viral junctions of DHBV DNA integrations in LMH cells
map in the 18-nucleotide region at the 3' terminus
of the minus strand
that would contain an RNA:DNA duplex in the
DSL DNA (Fig.
8A). The
viral junctions near the 5' terminus of
the minus strand are located in
the 70-bp cohesive overlap and
are more scattered than at the 3'
terminus of the minus strand.
This can be explained if the integration
substrate DSL DNAs had
contained an incompletely elongated DHBV plus
strand and therefore
had an SS region toward the 5' end of the minus
strand. An SS
region may be more susceptible than double-stranded DNA
to nuclease
digestions prior to or during the integration which would
lead
to greater heterogeneity at the 5' viral junction
sites.
The significance of 17-copy of the aaccct telomere repeat DNA directly
linked to DHBV
int1 is not known. Stretches of the
aaccct
sequence repeat are found primarily in the telomeres of
chromosomes
(
18). The opposite cellular flanking DNA of
int1
does not contain additional telomeric repeat sequence. One possibility
is that
int1 was integrated near the telomeric region of the
chromosome
at the borderline of telomere repeat sequence and other
repetitive
DNA. Another possibility is that
int1 was
integrated into other
regions of the chromosomes, e.g., centromeres,
that also contain
some telomeric repeat sequence. Still another
possibility involves
modification of the ends of the linear DHBV DNA or
the broken
ends of chromosomes by the telomerase complex during
integration.
It is known that telomerase can also synthesize telomeres
de novo
onto nontelomeric DNA termini in addition to elongating
preexisting
telomere tracts (
18). Telomerase activity can be
detected in
transformed cell lines, including LMH cells
(
34a).
 |
ACKNOWLEDGMENTS |
We thank Dan Loeb for graciously providing the 5/12 DHBV DSL
clone which was used to generate the LMH 66-1 DSL cell line. We also
thank Jesse Summers for his thoughts on approaches to calculating
integration frequencies and to thank William Mason for his critical
reading of the manuscript.
This work was supported by U.S. Public Health Service grant CA37232
from the National Cancer Institute (to C.E.R.), grant DK-17702 from the
Digestive Disease Center Grant Program, Cancer Center grant P30CA13330,
and NIH training grant CA09060 (to S.S.G.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Marion Bessin
Liver Research Center, Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461-1602. Phone: (718)
430-2607. Fax: (718) 430-8975. E-mail:
crogler{at}aecom.yu.edu.
Present address: Interferon Sciences, Inc., New Brunswick, NJ
08901-3660.
 |
REFERENCES |
| 1.
|
Buendia, M. A.
1992.
Hepatitis B virus and hepatocellular carcinoma.
Adv. Cancer Res.
59:167-226[Medline].
|
| 2.
|
Condreay, L.,
C. Aldrich,
L. Coates,
W. Mason, and T.-T. Wu.
1990.
Efficient duck hepatitis B virus production by an avian tumor cell line.
J. Virol.
64:3249-3258[Abstract/Free Full Text].
|
| 3.
|
Dejean, A.,
P. Sonigo,
S. Wain-Hobson, and P. Tiollais.
1984.
Specific hepatitis B virus integration in hepatocellular DNA through a viral 11-base-pair direct repeat.
Proc. Natl. Acad. Sci. USA
81:5350-5354[Abstract/Free Full Text].
|
| 4.
|
de The, H.,
A. Marchio,
P. Tiollais, and A. Dejean.
1987.
A novel thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma.
Nature (London)
347:294-298.
|
| 5.
|
Fourel, G.,
C. Trepo,
L. Bougueleret,
B. Hengelein,
A. Ponzetto,
P. Tiollais, and M. A. Buendia.
1990.
Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumors.
Nature
347:294-298[Medline].
|
| 6.
|
Fourel, G.,
J. Conturier,
Y. Wei,
F. Apiou,
P. Tiollais, and M. A. Buendia.
1994.
Evidence for long-range oncogene activation by hepadnavirus insertion.
EMBO J.
13:2526-2534[Medline].
|
| 7.
|
Ganem, D.
1996.
Hepadnaviridae and their replication, p. 2703-2737.
In
B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
|
| 8.
|
Gong, S. S.,
A. D. Jensen, and C. E. Rogler.
1996.
Loss and acquisition of duck hepatitis B virus integrations in lineages of LMH-D2 chicken hepatoma cells.
J. Virol.
70:2000-2007[Abstract].
|
| 9.
|
Gong, S. S.,
A. D. Jensen,
H. Wang, and C. E. Rogler.
1995.
Duck hepatitis B virus integrations in LMH chicken hepatoma cells: identification and characterization of new episomally derived integrations.
J. Virol.
69:8102-8108[Abstract].
|
| 9a.
| Gong, S., and C. Rogler. Unpublished data.
|
| 10.
|
Gracef, E.,
W. H. Caselmann,
J. Wells, and R. Koshy.
1994.
Insertional activation of mevalonate kinase by hepatitis B virus DNA in a human hepatoma cell line.
Oncogene
9:81-87[Medline].
|
| 11.
|
Hansen, L. J.,
B. C. Tennant,
C. Seeger, and D. Ganem.
1993.
Differential activation of myc family members in hepatic carcinogenesis by closely related hepatitis B viruses.
Mol. Cell. Biol.
13:659-667[Abstract/Free Full Text].
|
| 12.
|
Hatada, I.,
T. Tokino,
T. Ochiya, and K. Matsubara.
1988.
Co-amplification of integrated hepatitis B virus DNA and transforming gene hst-1 in hepatocellular carcinoma.
Oncogene
3:537-540[Medline].
|
| 13.
|
Hino, O.,
T. B. Shows, and C. E. Rogler.
1986.
Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17:18 translocation.
Proc. Natl. Acad. Sci. USA
83:8338-8342[Abstract/Free Full Text].
|
| 14.
|
Hu, J., and C. Seeger.
1996.
hsp90 is required for the activity of a hepatitis B virus reverse transcriptase.
Proc. Natl. Acad. Sci. USA
93:1060-1064[Abstract/Free Full Text].
|
| 15.
|
Kawaguchi, T.,
K. Nomura,
Y. Hirayama, and T. Kitagawa.
1987.
Establishment and characterization of a chicken hepatocellular carcinoma cell line LMH.
Cancer Res.
47:4460-4464[Abstract/Free Full Text].
|
| 16.
|
Koeck, J., and H.-J. Schlicht.
1993.
Analysis of the earliest steps of hepadnaviral replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity.
J. Virol.
67:4867-4874[Abstract/Free Full Text].
|
| 17.
|
Loeb, D. D.,
R. C. Hirsch, and D. Ganem.
1991.
Sequence-independent RNA cleavages generate the primers for plus strand DNA synthesis in hepatitis B virus: implication for other reverse transcribing elements.
EMBO J.
10:3533-3540[Medline].
|
| 18.
|
Melek, M.,
E. C. Greene, and D. E. Shippen.
1996.
Processing of nontelomeric 3' ends by telomerase: default template alignment and endonucleolytic cleavage.
Mol. Cell. Biol.
16:3437-3445[Abstract].
|
| 19.
|
Moroy, T.,
A. Marchio,
J. Etiemble,
C. Trepo,
P. Tiollais, and M. A. Buendia.
1986.
Rearrangement and enhanced expression of C-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks.
Nature (London)
324:276-279[Medline].
|
| 20.
|
Nagaya, T.,
T. Nakamua,
T. Tokina,
T. Tsurimoto,
M. Imai,
T. Mayumi,
K. Kamino,
K. Yamamura, and K. Matsubara.
1987.
The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma.
Genes Dev.
1:773-782[Abstract/Free Full Text].
|
| 21.
|
Peterson, J.,
M. Dandri,
A. Burkle,
L. Zhang, and C. Rogler.
1997.
Increase in the frequency of hepadnavirus DNA integrations of oxidative DNA damage and inhibition of DNA repair.
J. Virol.
71:5455-5463[Abstract].
|
| 22.
|
Rogler, C. E.
1991.
Cellular and molecular mechanisms of hepatocarcinogenesis associated with hepadnavirus infection.
Curr. Top. Microbiol. Immunol.
168:103-141[Medline].
|
| 23.
|
Rogler, C. E.,
M. Sherman,
C. Y. Su, and D. A. Shafritz.
1985.
Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma.
Science
230:319-322[Abstract/Free Full Text].
|
| 24.
|
Seeger, C.,
J. Summers, and W. S. Mason.
1991.
Viral DNA synthesis.
Curr. Top. Microbiol. Immunol.
168:41-61[Medline].
|
| 25.
|
Shaul, Y.,
P. D. Garcia,
S. Schonberg, and W. J. Rutter.
1986.
Integration of hepatitis B virus DNA in chromosome-specific satellite sequences.
J. Virol.
59:731-734[Abstract/Free Full Text].
|
| 26.
|
Shih, C.,
K. Burke,
M.-J. Chou,
J. B. Zeldis,
C.-S. Yang,
C.-S. Lee,
K. J. Isselbacher,
J. R. Wands, and H. M. Goodman.
1987.
Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region.
J. Virol.
61:3491-3498[Abstract/Free Full Text].
|
| 27.
|
Southern, E. M.
1975.
Detection of specific sequences among DNA fragments separated by gel electrophoresis.
J. Mol. Biol.
98:503-517[Medline].
|
| 28.
|
Sprengel, R.,
C. Kuhn,
H. Will, and H. Schaller.
1985.
Comparative sequence analysis of duck and human hepatitis B virus genome.
J. Med. Virol.
15:323-333[Medline].
|
| 29.
|
Staprans, S.,
D. D. Loeb, and D. Ganem.
1991.
Mutations affecting hepadnaviral plus-strand synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA.
J. Virol.
65:1255-1262[Abstract/Free Full Text].
|
| 30.
|
Summers, J., and W. Mason.
1982.
Replication of the genome of hepatitis B-like virus by reverse transcription of an RNA intermediate.
Cell
29:403-415[Medline].
|
| 31.
|
Szmuness, W.
1978.
Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.
Prog. Med. Virol.
24:40-69[Medline].
|
| 32.
|
Tuttleman, J.,
C. Pourcel, and J. Summers.
1986.
Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells.
Cell
47:451-460[Medline].
|
| 33.
|
Wang, G., and C. Seeger.
1993.
Novel mechanism for reverse transcription in hepatitis B viruses.
J. Virol.
67:6507-6512[Abstract/Free Full Text].
|
| 34.
|
Wang, H.-P., and C. E. Rogler.
1991.
Topoisomerase I-mediated integration of hepadnavirus DNA in vitro.
J. Virol.
65:2381-2392[Abstract/Free Full Text].
|
| 34a.
| Wang, H. P., and C. E. Rogler. Unpublished
data.
|
| 35.
|
Wang, J.,
F. Zindy,
X. Chenivesse,
E. Lamas,
B. Henglein, and C. Brechot.
1992.
Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma.
Oncogene
7:1653-1656[Medline].
|
| 36.
|
Wei, Y.,
G. Fourel,
A. Ponzetto,
M. Silvestro,
P. Tiollais, and M.-A. Buendia.
1992.
Hepadnavirus integration: mechanism of activation of the N-myc2 retrotransposon in woodchuck liver tumors.
J. Virol.
66:5265-5276[Abstract/Free Full Text].
|
| 37.
|
Yaninuma, K.,
H. Kobayashi,
T. Morishima,
K. Matsuyama, and K. Koike.
1987.
Multiple integration sites of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis tissues from children.
J. Virol.
61:1808-1813[Abstract/Free Full Text].
|
| 38.
|
Yang, W., and J. Summers.
1995.
Illegitimate replication of linear hepadnaviral DNA through nonhomologous recombination.
J. Virol.
69:4029-4036[Abstract].
|
Journal of Virology, February 1999, p. 1492-1502, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Mason, W. S., Low, H.-C., Xu, C., Aldrich, C. E., Scougall, C. A., Grosse, A., Clouston, A., Chavez, D., Litwin, S., Peri, S., Jilbert, A. R., Lanford, R. E.
(2009). Detection of Clonally Expanded Hepatocytes in Chimpanzees with Chronic Hepatitis B Virus Infection. J. Virol.
83: 8396-8408
[Abstract]
[Full Text]
-
Mason, W. S., Xu, C., Low, H. C., Saputelli, J., Aldrich, C. E., Scougall, C., Grosse, A., Colonno, R., Litwin, S., Jilbert, A. R.
(2009). The Amount of Hepatocyte Turnover That Occurred during Resolution of Transient Hepadnavirus Infections Was Lower When Virus Replication Was Inhibited with Entecavir. J. Virol.
83: 1778-1789
[Abstract]
[Full Text]
-
Mason, W. S., Jilbert, A. R., Summers, J.
(2005). Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection. Proc. Natl. Acad. Sci. USA
102: 1139-1144
[Abstract]
[Full Text]
-
Bill, C. A., Summers, J.
(2004). Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration. Proc. Natl. Acad. Sci. USA
101: 11135-11140
[Abstract]
[Full Text]
-
Summers, J., Mason, W. S.
(2004). Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy. Proc. Natl. Acad. Sci. USA
101: 638-640
[Abstract]
[Full Text]
-
Klocker, U., Oberwinkler, H., Kurschner, T., Protzer, U.
(2003). Presence of Replicating Virus in Recombinant Hepadnavirus Stocks Results from Recombination and Can Be Eliminated by the Use of a Packaging Cell Line. J. Virol.
77: 2873-2881
[Abstract]
[Full Text]
-
Yang, W., Summers, J.
(1999). Integration of Hepadnavirus DNA in Infected Liver: Evidence for a Linear Precursor. J. Virol.
73: 9710-9717
[Abstract]
[Full Text]